- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Positron delisted from NASDAQ
PET manufacturer Positron continues to be dogged by cash-flow problems. On July 7, the Houston-based vendor was delisted from the NASDAQ stock exchange, due to noncompliance with NASDAQ's minimum capital and surplus requirements.Financial difficulties
PET manufacturer Positron continues to be dogged by cash-flow problems. On July 7, the Houston-based vendor was delisted from the NASDAQ stock exchange, due to noncompliance with NASDAQ's minimum capital and surplus requirements.
Financial difficulties were also cited by the vendor in its decision not to exhibit at the annual meeting of the Society of Nuclear Medicine meeting in June (SCAN 6/25/97). Earlier, a deal to buy the PET assets of GE Medical Systems collapsed as a result of difficulties in securing funds for the acquisition (SCAN 4/30/97).
Positron's stock will now be traded on the OTC bulletin board. The company intends to reapply for listing as soon it completes its recapitalization and meets the minimum listing requirements, said Gary Wood, chairman.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
